Clincosm LogoSign in Get a demo

HCV

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV Trial (Education Intervention (The HepPEd Program))

Not yet recruiting
  • HCV
  • Education Intervention (The HepPEd Program)
  • (no location specified)
Jul 11, 2023

Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

Recruiting
  • Chronic Hepatitis C Virus
  • +4 more
  • Bucuresti, BUC, Romania
    Atea Study Site
Jun 15, 2023

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

HCV, Substance Use Disorders Trial in France, Martinique (Hybrid effectiveness-implementation study type 2)

Not yet recruiting
  • HCV
  • Substance Use Disorders
  • Hybrid effectiveness-implementation study type 2
  • Lyon, Auvergne-Rhône-Alpes, France
  • +3 more
Mar 20, 2023

Early Diagnosis of Hepatocellular Carcinoma (HCC)

Recruiting
  • HCC
  • +4 more
  • Biomarker dosage
  • Castellana Grotte, Bari, Italy
    RCCS "Saverio de Bellis"
Mar 23, 2023

HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))

Not yet recruiting
  • HCV
  • Prophylaxis (P2W)
  • Transmit and Treat (T&T)
  • New Orleans, Louisiana
  • +5 more
Dec 6, 2022

Male Infertility, HCV Trial in Al Qalyubiyah, Banha (Sofosbuvir +daclatasvir+ simeprevir+Ribavirin)

Recruiting
  • Male Infertility
  • HCV
  • Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
  • Al Qalyūbīyah, Benha, Egypt
  • +1 more
Nov 7, 2022

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

Hepatitis C, HCV Trial (Telehealth in Parole/Probation Office)

Recruiting
  • Hepatitis C
  • HCV
  • Telehealth in Parole/Probation Office
  • Lexington, Kentucky
    University of Kentucky
Oct 11, 2022

HIV, HCV, Drug Overdose Trial in Baltimore (HIV, HCV and overdose prevention)

Recruiting
  • HIV Infections
  • +2 more
  • HIV, HCV and overdose prevention
  • Baltimore, Maryland
    Lighthouse Studies at Peer Point
Sep 7, 2022

The South-East Asian Transgender Health Cohort

Recruiting
  • HIV
  • +2 more
    • Pasay, Manila, Philippines
    • +3 more
    Jul 11, 2022

    HIV, HCV Trial (Virtual Community Intervention, Standard of Care)

    Not yet recruiting
    • HIV Infections
    • HCV
    • Virtual Community Intervention
    • Standard of Care
    • (no location specified)
    May 2, 2022

    Alpha -1- Microglobulin asEarly Biomarker in Renal Extrahepatic

    Not yet recruiting
    • Renal Injury
    • HCV
      • (no location specified)
      May 3, 2022

      Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce

      Active, not recruiting
      • HCV
      • +2 more
      • Evaluate model of care for HCV-infected adults with on-going opioid misuse
      • Washington, District of Columbia
      • +1 more
      Feb 2, 2022

      Hepatic Decompensation and Survival Outcomes in Pediatric

      Recruiting
      • Cirrhosis
      • +6 more
      • Prediction model
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Jan 5, 2022

      HCV, HBV, Hiv Trial in Paris (HCV, HBV, HIV tests)

      Terminated
      • HCV
      • +2 more
      • HCV, HBV, HIV tests
      • Paris, France
        Lariboisière
      Nov 19, 2021

      Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir

      Completed
      • Kidney Transplant
      • +2 more
      • Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
      • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
      • Columbus, Ohio
        Brenda Cuson
      Jul 29, 2021

      HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

      Completed
      Has Results
      • HCV
      • +2 more
      • (no location specified)
      Jul 28, 2021

      Access Anti-HCV Assay European Union Clinical Trial Protocol

      Completed
      • HCV
      • Access HCV
      • Bois-Guillaume, France
      • +2 more
      Jul 12, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

      Completed
      • Hepatitis C
      • HCV
      • San Antonio, Texas
        Texas Liver Institute
      Jan 15, 2021

      HCV Trial in Bonn, 's-Hertogenbosch, Nijmegen (sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed)

      Withdrawn
      • HCV
      • sofosbuvir/velpatasvir tablet
      • sofosbuvir/velpatasvir crushed
      • Bonn, Germany
      • +2 more
      Dec 4, 2020

      Prognostic Model of HCV-related Disease Progression After DAAs

      Not yet recruiting
      • HCV
        • (no location specified)
        Nov 15, 2020